-+ 0.00%
-+ 0.00%
-+ 0.00%

Jinling Pharmaceutical (000919.SZ) subsidiary Allolol hydrochloride API approved for listing

Zhitongcaijing·09/22/2026 08:25:04
Listen to the news

Zhitong Finance App News, Jinling Pharmaceutical (000919.SZ) issued an announcement. Chizhou Dongsheng Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received the “Notice of Approval of the Marketing Application for Chemical Ingredients” for allolol hydrochloride issued by the State Drug Administration. Allolol hydrochloride is a receptor blocker that simultaneously blocks alpha and beta receptors. Its formulation products are mainly used to treat diseases such as essential hypertension (mild to moderate) and angina pectoris.